History
  • No items yet
midpage
724 F.Supp.3d 260
S.D.N.Y.
2024
Read the full case

Background

  • Purdue Pharma and its affiliates filed for bankruptcy in 2019, facing widespread litigation tied to their opioid business.
  • The U.S. government filed multiple criminal and civil claims against Purdue, including claims for billions in forfeiture, fines, and damages.
  • Purdue and the U.S. reached a plea agreement and a civil settlement in October 2020; these agreements gave the U.S. several high-priority claims in the bankruptcy estate, codified in a Bankruptcy Court order (the "9019 Order").
  • Appellants Bridges and Bloyd did not object to or appeal the 9019 Motion or Order.
  • In August 2021, Appellants filed an adversary proceeding seeking to equitably subordinate the U.S.'s claims, claiming their rights as victims were ignored under the Mandatory Victims Restitution Act (MVRA).
  • The Bankruptcy Court dismissed their complaint for failure to state a claim, and Appellants appealed.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Collateral Attack on 9019 Order Appellants can challenge the priority and treatment of U.S. claims despite not objecting to or appealing the order. Appellants forfeited the right to challenge by not objecting or appealing; collateral attacks are barred. Court held the complaint was an impermissible collateral attack; 9019 Order is final.
Equitable Subordination U.S. acted inequitably by waiving victim restitution under MVRA and prioritizing its own claims. No fraud or egregious conduct; prosecutorial discretion applies; MVRA doesn't create such a duty. Court found no inequitable conduct, and claim did not meet legal standard.
Application of MVRA MVRA obligated restitution to victims in the bankruptcy context. MVRA doesn't apply to bankruptcy distribution or create a private right of action against U.S. Court agreed with defendants; MVRA inapplicable here.
Consistency with Bankruptcy Code Bankruptcy court can use equitable subordination to reorder priorities. Equitable subordination inconsistent here because MVRA grants no legal right to relief; can't expand non-bankruptcy rights in bankruptcy. Court found equitable subordination would be inconsistent with the Bankruptcy Code.

Key Cases Cited

  • In re Purdue Pharma, L.P., 635 B.R. 26 (S.D.N.Y. 2021) (context for "tsunami of litigation" against Purdue)
  • AEC One Stop Grp., Inc. v. Bain Cap. Fund IV L.P., 9 F. App’x 53 (2d Cir. 2001) (final, unappealed orders cannot be collaterally attacked)
  • In re Mobile Steel Co., 563 F.2d 692 (5th Cir. 1977) (sets out standards for equitable subordination)
  • United States v. Batchelder, 442 U.S. 114 (1979) (prosecutorial discretion in charging decisions)
  • Heckler v. Chaney, 470 U.S. 821 (1985) (prosecutorial discretion is not judicially reviewable)
Read the full case

Case Details

Case Name: In Re: Purdue Pharma L.P.
Court Name: District Court, S.D. New York
Date Published: Mar 20, 2024
Citations: 724 F.Supp.3d 260; 7:23-cv-03779
Docket Number: 7:23-cv-03779
Court Abbreviation: S.D.N.Y.
Log In